Lee's Pharmaceutical Holdings Limited

HKG:8221 ISIN:KYG5438W1033

 Lee's Pharmaceutical Holdings Limited (8221.HK) is a public biopharmaceutical company with over 14 years operation in China's pharmaceutical industry. It is fully integrated with solid infrastructures in drug development, clinical development, regulatory, manufacturing, sales and marketing in China with global perspectives and currently markets six products. Lee's Pharm focuses on several different areas such as cardiovascular and infectious diseases, dermatology, oncology, gynecology and others. It has more than 20 products under different development stages stemming from both internal R&D as well as from the recent acquisition of licensing and distribution rights from various US and European companies. The mission of Lee's Pharm is to become a successful biopharmaceutical group in Asia providing innovative products to fight diseases and improve health and quality of life.  
 
  

View in Other Languages

News

Lee's Pharmaceutical (HKG:8221) 2009 Interim Net Profit Soared 62.5% Proprietary Products and Production Efficiency Performance Remained Strong

🕔8/14/2009 6:06:29 PM 7318

Lee's Pharmaceutical Holdings Limited ("Lee's Pharmaceutical" or the "Group", HKG:8221), an integrated research-driven and market-oriented pharmaceutical group in China, today announced its interim results for the six months ended 30 June 2009 (the "period under review").

Read Full Article

Lee's Pharmaceutical (HKG:8221) to Have Strategic Partner as Shareholder To Broaden Shareholder Base and Product Mix

🕔8/11/2009 9:54:24 PM 5584

Lee's Pharmaceutical Holdings Limited ("Lee's Pharmaceutical" or the "Group", Stock Code: HKG:8221) is an integrated, research-driven and market-oriented pharmaceuticals group in China, signed a subscription agreement with Vivo Ventures Fund Cayman VI. L. P. (Vivo Ventures Fund), allowing the Group to enter into a strategic partnership with a financial investor experienced in biotechnology and pharmaceutical business.

Read Full Article

Lee's Pharmaceutical Holdings Limited's (HKG:8221) Profit Surged 86% in 1Q2009 Achieved Nine Consecutive Quarters of Double Digit Growth

🕔5/15/2009 2:20:40 PM 4022

Lee's Pharmaceutical Holdings Limited's (HKG:8221) today announced its unaudited consolidated results for the three months ended 31 March 2009 (the "period under review").

Read Full Article

Lee's Pharmaceutical Holdings Limited (HKG:8221) a Heart Beating 63.5% Revenue Growth in 2008

🕔4/3/2009 6:44:09 PM 4414

Lee's Pharmaceutical (HKG:8221) specialises in R&D, manufacturing, sales and marketing of prescription drugs in China and HK. They focus on cardiovascular, gynaecological, dermatological and ophthalmology diseases treatments, with over 5,000 hospitals currently using their products nationwide.

Read Full Article
###

21,357 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 14) (Last 30 Days: 72) (Since Published: 6583) 

Company Data

    Telephone
  • +852-2314-1282 
  • Principal Sector
  • Health & Pharm General 
  • Principal Industry
  • Pharmaceutical 
  • Homepage
  • www.leespharm.com